InvestorsHub Logo
Post# of 251888
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: ciotera post# 168238

Wednesday, 10/16/2013 6:15:43 AM

Wednesday, October 16, 2013 6:15:43 AM

Post# of 251888

but eGFR decline will be the marketing message of ViiV

In the once-daily-fixed-dose combo pills fight, GILD's next move is TAF-quad (in phase III trials) that in phase II showed a better AE (kidneys and bones) profile vs. Stribild.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.